About Channel

This channel provides evidence-informed, science-based information on ivermectin—its pharmacology, clinical research status, regulatory positions (FDA, WHO, EMA), and appropriate use contexts—alongside practical, up-to-date guidance on influenza prevention, symptom management, and recovery. It also covers COVID-19 solutions grounded in current public health recommendations: vaccination updates, antiviral treatments (e.g., Paxlovid, molnupiravir), rapid testing strategies, and non-pharmaceutical interventions like ventilation and masking. Content avoids misinformation by citing peer-reviewed studies, systematic reviews, and official health authority statements—clearly distinguishing between approved uses, off-label applications under medical supervision, and disproven claims. The channel does not promote ivermectin as a universal or unproven treatment for viral respiratory illnesses but emphasizes risk-benefit analysis, contraindications, and the importance of clinician consultation. Targeted at health-conscious individuals, caregivers, and non-specialist professionals seeking reliable, jargon-reduced summaries, it prioritizes clarity, transparency about evidence quality (e.g., RCTs vs. observational data), and ethical communication. Regular posts include comparative efficacy charts, timeline-based updates on evolving guidelines, myth-vs-fact breakdowns, and links to primary sources. While focused on respiratory virus preparedness, the channel also addresses related topics such as immune support through nutrition and sleep hygiene—always anchored in reproducible science—not anecdote or ideology. No medical advice is dispensed; all content includes disclaimers urging readers to consult licensed providers for personal health decisions.

Comments(2)

Write a comment
82.***.***.0 (Samarkand)
2026-04-26 02:19:57

O'quv materiallari sifatli va bepul.",

84.***.***.0 (Tashkent)
2026-02-19 16:19:57

Texnologiya sohasidagi trendlarni kuzataman.",